|DNA Commission of the International Society of Forensic Genetics (ISFG): an update of the recommendations on the use of Y-STRs in forensic analysis|
L Gusmao, JM Butler, A Carracedo, P Gill, M Kayser, WR Mayr, N Morling, ...
International journal of legal medicine 120 (4), 191-200, 2006
|Germline Mutations in the PTEN/MMAC1 Gene in Patients With Cowden Disease|
MR Nelen, WCG Van Staveren, EAJ Peeters, M Ben Hassel, RJ Gorlin, ...
Human molecular genetics 6 (8), 1383-1387, 1997
|Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts|
HFA Vasen, I Blanco, K Aktan-Collan, JP Gopie, A Alonso, S Aretz, ...
Gut 62 (6), 812-823, 2013
|Clinical findings with implications for genetic testing in families with clustering of colorectal cancer|
JT Wijnen, HFA Vasen, PM Khan, AH Zwinderman, H Van Der Klift, ...
New England Journal of Medicine 339 (8), 511-518, 1998
|Familial endometrial cancer in female carriers of MSH6 germline mutations|
J Wijnen, W de Leeuw, H Vasen, H van der Klift, P Møller, A Stormorken, ...
Nature genetics 23 (2), 142, 1999
|Association of hereditary nonpolyposis colorectal cancer–related tumors displaying low microsatellite instability with MSH6 germline mutations|
Y Wu, MJW Berends, RGJ Mensink, C Kempinga, RH Sijmons, ...
The American Journal of Human Genetics 65 (5), 1291-1298, 1999
|Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical‐mediated hepatic injury|
BG Harbrecht, TR Billiar, J Stadler, AJ Demetris, J Ochoa, RD Curran, ...
Journal of leukocyte biology 52 (4), 390-394, 1992
|Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant|
MJW Berends, Y Wu, RH Sijmons, RGJ Mensink, T van der Sluis, ...
The American Journal of Human Genetics 70 (1), 26-37, 2002
|Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database|
BA Thompson, AB Spurdle, JP Plazzer, MS Greenblatt, K Akagi, ...
Nature genetics 46 (2), 107, 2014
|Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke|
DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ...
American journal of preventive medicine 20 (2), 16-66, 2001
|Targeted next‐generation sequencing can replace Sanger sequencing in clinical diagnostics|
B Sikkema‐Raddatz, LF Johansson, EN de Boer, R Almomani, LG Boven, ...
Human mutation 34 (7), 1035-1042, 2013
|TP53 germline mutation testing in 180 families suspected of Li–Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes|
MWG Ruijs, S Verhoef, MA Rookus, R Pruntel, AH van der Hout, ...
Journal of medical genetics 47 (6), 421-428, 2010
|Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status|
C Oliveira, JL Westra, D Arango, M Ollikainen, E Domingo, A Ferreira, ...
Human molecular genetics 13 (19), 2303-2311, 2004
|Low-penetrance genes and their involvement in colorectal cancer susceptibility|
MM de Jong, IM Nolte, GJ te Meerman, WTA van der Graaf, EGE de Vries, ...
Cancer Epidemiology and Prevention Biomarkers 11 (11), 1332-1352, 2002
|Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study|
MJE Kempers, RP Kuiper, CW Ockeloen, PO Chappuis, P Hutter, ...
The lancet oncology 12 (1), 49-55, 2011
|Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP)|
M Nielsen, PF Franken, T Reinards, MM Weiss, A Wagner, H Van der Klift, ...
Journal of medical genetics 42 (9), e54-e54, 2005
|A role for MLH3 in hereditary nonpolyposis colorectal cancer|
Y Wu, MJW Berends, RH Sijmons, RGJ Mensink, E Verlind, KA Kooi, ...
Nature genetics 29 (2), 137, 2001
|Risks of less common cancers in proven mutation carriers with lynch syndrome|
C Engel, M Loeffler, V Steinke, N Rahner, E Holinski-Feder, W Dietmaier, ...
J Clin Oncol 30 (35), 4409-15, 2012
|A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families|
T Peelen, M Van Vliet, A Petrij-Bosch, R Mieremet, C Szabo, ...
American journal of human genetics 60 (5), 1041, 1997
|Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations|
RP Zweemer, PJ Van Diest, RHM Verheijen, A Ryan, JJP Gille, ...
Gynecologic oncology 76 (1), 45-50, 2000